Director Jin David bought Mustang Bio Inc. ($MBIO) shares once on the open market in the last year, totaling $237.61 with the latest purchase on December 30, 2025. He reported no sales. His buying ranks 4,853rd out of 4,983 insiders, well below the average $1.46 million per person across about 3.3 transactions.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Fortress Biotech, Inc. | $FBIO | Jin David | Chief Financial Officer | A | Common Stock, par value $0.001 | 2967 | $2.18 | 1,251,571.0000 | 33,100,961 | 0.24% | 0.01% |
| Dec. 30, 2025 | MUSTANG BIO, INC. | $MBIO | Jin David | Director | P | COMMON STOCK, PAR VALUE $0.0001 | 247 | $0.96 | 286.0000 | 6,241,658 | 633.33% | 0.00% |
| Oct. 1, 2025 | Fortress Biotech, Inc. | $FBIO | Jin David | Chief Financial Officer | A | Common Stock, par value $0.001 | 2711 | $1.31 | 1,248,604.0000 | 33,100,961 | 0.22% | 0.01% |
| April 1, 2025 | Fortress Biotech, Inc. | $FBIO | Jin David | Chief Financial Officer | A | Common Stock, par value $0.001 | 5000 | $1.22 | 1,245,893.0000 | 26,450,218 | 0.40% | 0.02% |
| Dec. 19, 2024 | Fortress Biotech, Inc. | $FBIO | Jin David | Chief Financial Officer | A | Common Stock, par value $0.001 | 1000000 | $0.00 | 1,240,893.0000 | 19,697,290 | 415.12% | 5.08% |
| Oct. 1, 2024 | Fortress Biotech, Inc. | $FBIO | Jin David | Chief Financial Officer | A | Common Stock, par value $0.001 | 2625 | $1.23 | 240,893.0000 | 19,697,290 | 1.10% | 0.01% |
| Sept. 23, 2024 | AVENUE THERAPEUTICS, INC. | $ATXI | Jin David | Interim PFO and COO | A | COMMON STOCK, PAR VALUE $0.0001 | 65000 | $0.00 | 65,000.0000 | 341,324 | 9999.99% | 19.04% |
| July 10, 2024 | Fortress Biotech, Inc. | $FBIO | Jin David | Chief Financial Officer | P | SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK | 500 | $7.50 | 500.0000 | 18,316,874 | 9999.99% | 0.00% |
| April 1, 2024 | Fortress Biotech, Inc. | $FBIO | Jin David | Chief Financial Officer | A | COMMON STOCK, PAR VALUE $0.001 | 2352 | $1.70 | 238,268.0000 | 17,151,945 | 1.00% | 0.01% |
| June 30, 2023 | AVENUE THERAPEUTICS, INC. | $ATXI | Jin David | Interim PFO and COO | A | Employee stock option (right to buy) | 250000 | $0.00 | 250,000.0000 | 0 | 9999.99% | 0.00% |